Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Amgen Inc. is a leading biotechnology company focused on developing innovative medicines for serious diseases. With a robust pipeline, it offers products like Enbrel, Repatha, and Otezla, targeting high unmet medical needs. Amgen operates globally, leveraging advanced manufacturing technologies to enhance efficiency and sustainability. Recent initiatives include the FDA approvals of IMDELLTRA and MariTide, addressing cancer and obesity, respectively, while expanding access through strategic partnerships.
This description was generated via AI from an annual report. Updated about 1 year ago.